Services on Demand
Journal
Article
Portuguese (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Similars in
SciELO
Share
Permalink
Revista Portuguesa de Medicina Geral e Familiar
Print version ISSN 2182-5173
Abstract
OLIVEIRA, Andreia; PARAISO, Rita; LOBAO, Paola and GUERREIRO, Vanessa. Rhabdomyolysis secondary to COVID-19 vaccination: case report. Rev Port Med Geral Fam [online]. 2023, vol.39, n.1, pp.46-50. Epub Mar 30, 2023. ISSN 2182-5173. https://doi.org/10.32385/rpmgf.v39i1.13545.
Introduction:
Rhabdomyolysis is characterized by skeletal muscle injury. It has been described as a complication of COVID-19 infection, but few cases associated with COVID-19 vaccination have been reported.
Case report:
After the hospital discharge of an 80-year-old female patient, the family doctor received the admission report for pain and weakness in her lower limbs. Common causes of rhabdomyolysis were excluded; however, it is noteworthy that she had been given the first dose of the vaccine against COVID-19 (Vaxzevria®) one day prior to admission. After management, the symptoms improved, and she was discharged. After a complete evaluation, the patient was found to have vaccine-related rhabdomyolysis, becoming one of the first cases of rhabdomyolysis following an adenoviral vector-based vaccine for COVID-19.
Comment:
Physicians should be aware of the possibility of COVID-19 vaccine-induced rhabdomyolysis as a potentially serious side-effect in patients with myalgia, weakness, and dark urine. Nonetheless, the benefit-risk assessment shows a favorable balance.
Keywords : Rhabdomyolysis; Vaccine; COVID-19.
